DermTopic: Psoriasis

Filter Your Results

 

News

 

XELJANZ Receives EU Marketing Authorization for Adults with …

The European Commission (EC) has approved XELJANZ® (tofacitinib citrate) 5 mg twice daily (BID) in combination with …

UVBioTek Launches POLY Go Portable LED Light Therapy

UVBioTek has launched a new line of hand-held LED therapy products that support their newest brand, POLY LED Light Thera…

LEO Pharma and Advancing Innovation in Dermatology Partner t…

LEO Pharma and its Boston-based R&D innovation unit LEO Science & Tech Hub, and Advancing Innovation in Dermatol…

FDA-Approved Label Update: Cosentyx Inhibits Progression of …

The US FDA has approved a label update for Cosentyx® (secukinumab) from Novartis, including data that show the treat…

Valeant: FDA Issues Complete Response Letter for Duobrii

Ortho Dermatologics, a division of Valeant Pharmaceuticals International, Inc. has received a Complete Response Let…

Digital Innovation to the Rescue: The Future of Electronic P…

GR is a 45-year-old man who has been suffering from psoriasis for the past five years. It has negatively affected his se…

Michael Sherling, MD, MBA

Recent Developments

FDA Greenlights Restylane Lyft for Hand Rejuvenation Restylane Lyft is the first hyaluronic acid (HA) injectable gel …

Currents: The Picture Issue

Could Teledermoscopy Speed Time to Case Resolution in Skin Cancer? Teledermatology for skin cancer referral and triag…

 
 

Contact Info

For advertising rates and opportunities:
Ali Kinnie
(917) 589-4160
akinnie@bmctoday.com

Rick Ehrlich
Associate Publisher
(609) 922-0337
rehrlich@bmctoday.com

About Practical Dermatology

Practical Dermatology is the monthly publication that provides coverage of medical care, cosmetic advancements, and practice management for clinicians in the field. With straight-forward, how-to advice from experts in various fields, we strive to enhance quality of care and improve the daily operation of dermatology practices.